Progyny, Inc. (NASDAQ:PGNY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ten brokerages that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that […]